THE INTRODUCTION of the adrenergic beta-receptor blocking agent, pronethalol,1 and the more recent availability of its analogue propranolol2 have served as a new impetus in the pharmacological study of the cardiovascular system. Clinical use of these compounds has been explored in the treatment of hypertension,3 angina pectoris,4 prolonged systemic hypotension,5 hypertrophic subaortic stenosis,6 and pheochromocytoma.7 A fundamental effect of the beta-receptor blocking agents is their ability to slow the heart rate, and for this reason Black and Stephenson' suggested their use in certain cardiac arrhythmias. Stock and Dale8 found that pronethalol slowed the ventricular rate in patients with atrial fibrillation. This effect was particularly noticeable in the digitalized patient.
Although pronethalol (Nethalide; Alderlin) proved to be carcinogenic in mice,9 its successor, propranolol (Inderal), has not been. Recent studies'0 11 have demonstrated the latter to be effective in decreasing the frequency of the ventricular response in patients with atrial fibrillation, atrial flutter, and ectopic atrial tachycardia when it was given intravenously. The present report further confirms the ability of propranolol to slow the ventricular rate in digitalized patients with supraventricular arrhythmias. Our The effect of propranolol on the heart rate after exercise was studied in seven patients who were receiving digitalis. During a control period of 3 days, the dosage of digitalis was stabilized and a standard two-step electrocardiographic exercise test was performed daily. Thereafter, treatment with digitalis was continued and propranolol was administered by mouth four times daily. The latter was increased in increments of 10 mg per dose daily until it was concluded that an adequate drug effect, that is, optimal slowing of the heart rate without the undesired effects described below had been obtained. Heart rates were determined during the last 2 days of the control period and during the The ventricular rate was slowed in all patients with atrial fibrillation when propranolol was given intravenously or orally.
The ventricular response at rest was slowed in nine of the 10 patients with chronic atrial fibrillation and the increase in ventricular rate was less after exercise than before propranolol was given in all seven patients exercised ( In three patients without demonstrable evidence of hyperthyroidism a persistent sinus rhythmias due to digitalis became hypotensive after they were given intravenous propranolol. One of these patients also developed sinoatrial block. Both of these patients died and at postmortem examination both had pulmonary emboli.
Discussion
Considerable evidence now indicates that pronethalol, and undoubtedly also its cogener propranolol, have several modes of action on cardiac rhythm. Singer and associates12 have demonstrated that the sinus slowing, atrioventricular block, and depressed ventricular automaticity produced by pronethalol are probably mediated by beta-adrenergic blockade. However, the effects on the atria of increasing refractoriness, slowing of conduction, and depressing excitability appear to be due to direct muscular action and do not appear to be related to the neuroreceptors. Others'3 have also suggested that pronethalol may have such a "quinidine-like" effect on the electrical properties of the myocardium. This latter action has been invoked as the mechanism whereby pronethalol reversed digitalis-induced arrhythmias, especially since its dextro-isomer (a compound 40 times less active in producing adrenergic beta-receptor blockade) similarly antagonized arrhythmias resulting from ouabain or acetylstrophanthidin.14 Taylor and Halliday,15 however, have suggested that this specific anti-arrhythmic effect may be related to a reduction in the amount of loss of intracellular potassium produced by the cardiac glycosides.
Many of these effects, particularly on heart rate and atrioventricular conduction, could not be reproduced by in the unanesthetized dog with either pronethCirculation, Volume XXXIV, November 1966 alol or propranolol. This is not consonant with clinical experience and the exact mechanisms of anti-arrhythmic action of these drugs thus remain unclarified. It is evident, though, that studies in animals with normal hearts cannot be directly related to patients with severe heart disease who are often receiving digitalis.
Slowing of the ventricular response to atrial fibrillation or to other supraventricular tachycardias as demonstrated in the present study and by others10 11 may be explained by blockade of adrenergic influences on the atrioventricular junction. Previous studies'7 have indicated that depletion of myocardial norepinephrine stores results in a prolongation of the atrioventricular junctional refractory period. Neuroreceptor blockade would be expected to have a similar effect.
On the other hand, in three patients paroxysmal tachycardias which were consistently provoked by a variety of stimuli (Gallavardin's "tachycardie paroxystique a centre excitable"'8) were prevented, rather than merely slowed, by propranolol. Since quinidine was previously ineffective in these patients, it is likely that propranolol abolished these arrhythmias by blockade of exogenous sympathetic stimuli to the heart. Slowing of clinically troublesome sinus tachycardias in three other patients may be similarly interpreted (table 1) .
The direct depressant action of propranolol was demonstrated in the patient with repetitive tachycardia. A lengthening of the pauses between runs of rapid heart action ( fig. 1 ) may be due to an effect on either impulse formation or impulse conduction in the atria.
In six of the seven patients with digitalisinduced arrhythmias the intravenous use of propranolol appeared both dramatic and specific. Indeed, the fact that only transient ventricular slowing occurred with propranolol in the seventh patient might imply that her ectopic atrial tachycardia was not engendered by digitalis. Further study is indicated to determine whether propranolol can be employed as a specific test of digitalis excess or toxicity as defined by Pick 
